BCP Partnering Portal / Genomictree Inc
Genomictree Inc
Genomictree Inc
Company Type:
Manufacturer
Business Address:
44-6 Techno 10-ro Yuseong
Daejeon
34027
South Korea
Daejeon
34027
South Korea
Business Address:
12F 364 Gangnam-dearo Gangnam-gu
Seoul
06241
South Korea
Seoul
06241
South Korea
Business Address:
44-6, Techno 10-ro
Yuseong-gu
Daejeon
34027
South Korea
Yuseong-gu
Daejeon
34027
South Korea
Phone:
+82 428 614 551
Phone:
82-42-861-4551
Website:
Company Overview:
Genomictree Inc is a biomarker-based molecular diagnostic company that develops and provides DNA methylation biomarker-based non-invasive molecular tests for the early detection of cancers and infectious diseases. Founded in 2000 and listed on KOSDAQ in 2019, the company aims to improve the quality of life for humanity and reduce total medical expenditure. Genomictree's strategy involves the efficient discovery of methylation biomarkers, establishment of clinical evidence, development of accurate measuring techniques, and validation of clinical effectiveness and utility. The company offers products such as EarlyTect for colon, lung, and bladder cancer detection, as well as AccuraTect for SARS-CoV-2 RT-qPCR testing.
About Us:
Genomictree, Inc. was founded in 2000 and listed at KOSDAQ(Korea Securities Dealers Automated Quotation) in 2019. We are specialized in molecular diagnostics to develop and provide DNA methylation biomarker-based non-invasive molecular tests to support effective early detection of cancers and infectious diseases.
Genomictree (228760 KOSDAQ) is biomarker-based molecular diagnostic company for early cancer detection.
We were founded with the vision of developing innovative biomarker-based in vitro early cancer diagnosis technologies and products to satisfy the unmet needs of healthcare markets, thereby contributing to improving the quality of life for humanity, and the reduction of total medical expenditure.
Abnormal DNA methylation is epigenetic mutation that occurs in cancer cells. Our strategy for development and commercialization of early cancer detection technology involves: 1) Efficient discovery of methylation biomarkers using our own biomarker discovery engine, 2) establishment of clinical evidence for early cancer diagnosis to acquire intellectual property rights, 3) development of accurate measuring techniques that are able to detect biomarkers in bodily fluids (liquid biopsy), while maintaining high sensitivity and specificity, and 4) validation of clinical effectiveness and utility with bodily fluids.
Applications, Products & Services:
EarlyTect® Colon Cancer
EarlyTect® Lung Cancer
EarlyTect® Bladder Cancer
AccuraTect™
Test Providers
AccuraDTect™ SARS-CoV-2 RT-qPCR Kit
Industry:
Medical Equipment & Supplies
Clinical / Diagnostics
Life Sciences
Pharma & Biotech
Product Type:
Reagents & Kits
Products, Services & Applications:
Diagnostics
Detection
Diagnostics: Molecular
Point of Care / Rapid Tests
Diagnostics: Clinical
Diagnostics: Infectious Diseases
Looking for Distributors in Regions:
Europe
Africa
Asia Pacific
Eastern/Central Europe
Middle East
North America
South America
The BCP Partnering Portal
Where Manufacturers and Channel Partners / Distributors find each other!
- The BCP Partnering Portal is a specialized matchmaking platform featuring over 28,000 company profiles, who supply products and services within scientific fields. It serves as a crucial resource for facilitating B2B partnerships between manufacturers and channel partners.
- Developed by BioChannel Partners Ltd, an award-winning B2B partnering company with over 22 years of expertise in connecting manufacturers and channel partners of scientific products, the portal ensures that company profiles are kept up-to-date by both the BCP team and verified profile owners.
- This continuous update process ensures that users have access to accurate and current information, enhancing the platform's effectiveness in fostering successful business collaborations.
- Take advantage of this resource and join to manage your own company profile and search for new partners.